A Case of Diffuse Large B-Cell Lymphoma(DLBCL)Who Died of Acute Exacerbation of Interstitial Pneumonia after Treatment with R-mini-CHP in Combination with Polatuzumab Vedotin (Pola-R-mini-CHP).
1/5 보강
84-year-old male was diagnosed with diffuse large B-cell lymphoma.He had Stage Ⅳ, performance status was 2, and 'high risk' according to the International Prognostic Index.He was started on Pola-R-min
APA
Sekiguchi Y, Tsutsumi H, et al. (2026). A Case of Diffuse Large B-Cell Lymphoma(DLBCL)Who Died of Acute Exacerbation of Interstitial Pneumonia after Treatment with R-mini-CHP in Combination with Polatuzumab Vedotin (Pola-R-mini-CHP).. Gan to kagaku ryoho. Cancer & chemotherapy, 53(1), 31-34.
MLA
Sekiguchi Y, et al.. "A Case of Diffuse Large B-Cell Lymphoma(DLBCL)Who Died of Acute Exacerbation of Interstitial Pneumonia after Treatment with R-mini-CHP in Combination with Polatuzumab Vedotin (Pola-R-mini-CHP).." Gan to kagaku ryoho. Cancer & chemotherapy, vol. 53, no. 1, 2026, pp. 31-34.
PMID
41555173 ↗
Abstract 한글 요약
84-year-old male was diagnosed with diffuse large B-cell lymphoma.He had Stage Ⅳ, performance status was 2, and 'high risk' according to the International Prognostic Index.He was started on Pola-R-mini-CHP.The day after completion of the 4 cycle, he developed shortness of breath, and we diagnosed he as having exacerbation of interstitial lung disease by CT.We started steroid pulse therapy.However, his condition failed to improve, and he died.An autopsy was performed.The pathological diagnosis was pulmonary fibrosis with acute diffuse alveolar damage.It is necessary to carefully monitor patients receiving Pola-R-CHP.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
- Diffuse Large B-cell Lymphoma Complicated by Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity on Day 355 of Epcoritamab Therapy: A Case Report.
- Clinical outcomes of carbon-ion radiotherapy for residual or recurrent hepatocellular carcinoma after transarterial chemoembolization.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.